Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline alphoscerate for older adults with major depression and subjective memory complaints
KCT0007062Phase 4Completed
- Sponsor
- Daewoong Bio
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Choline alphoscerate with Placebo (2 arms). Started Aug 2022; status: completed.
02
Drugs
choline alfoscerate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on KCT0007062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007062.